Forbion raises $240M investment fundFierceBiotechThe VC–which has offices in the Netherlands and Germany–aims to invest most of the money in Europe and the remainder in North America and Israel. …
and more »

Related PostsJune 28, 2010 — Shrink Nanotechnologies Enters into Technology Integration and Development … – MarketWatch (press release)April 12, 2010 — Charter Medical Launches New [...]

Abbott bows out of Flutiform pactFierceBiotechThe company has filed a Flutiform app in Europe and is also pursuing Japanese approval of the drug, with Phase III trials expected to begin in March 2011.
and more »

Related PostsAugust 11, 2010 — Karo Bio to present clinical phase III development plan for eprotirome as a … – CisionWire (press [...]

European shares edge up; Goldman Sachs awaitedInvesting ContrarianShares in Europe’s largest biotech Actelion rose 5.3% when it confirmed its 2010 outlook after stronger-than-expected sales of its key heart and lung drug …
and more »

Related PostsJuly 20, 2010 — European shares fall for fifth day; banks down – ReutersApril 22, 2010 — Actelion sticks to 2010 goals [...]

EU seeks to clear way for GM cropsSydney Morning HeraldA maize seed developed by US biotech giant Monsanto, MON 810, is the only crop to have been cleared for commercial cultivation in Europe since 1998. …
and more »

Technorati Tags: Biotech, Biotech USA

Outsource to EuropePharmiWeb.com (press release)Simon Orchard the : VP Biotech Operating Unit Europe and Managing Director of the Strängnäs site (Sweden) and CEO for Pfizer Health AB is only to aware of …

Related PostsJanuary 11, 2010 — PharmaNet Development Group Symposia 'Crossing the Bridge from Preclinical to … – PR Newswire (press release)August 12, 2010 [...]

Shrink Nanotechnologies Enters into Technology Integration and Development …MarketWatch (press release)With operations in the US, France, the Netherlands and Germany and sales offices in the US, Europe, and Asia, focuses on manufacturing specialty engineered …
and more »

Related PostsJanuary 7, 2010 — Charter Medical Names New Vice President – Global Sales and Marketing – CNNMoney.com (press release)April [...]

Sanofi’s Multaq Likely To Be Cheaper Than Rivals In FranceWall Street JournalThe drug was approved for use in Europe last year and entered the UK market in March. It is also sold in Germany, the US, Denmark, Norway, …
and more »

Related PostsJune 15, 2010 — UDPATE 1-Sanofi's Multaq improves in French test – ReutersSeptember 3, 2010 [...]

TKL Research Expands Capability in EuropePR Newswire (press release)Our past success in conducting quality clinical trials in Europe will be further enhanced by having a European office in Germany. …
and more »

Related PostsSeptember 3, 2010 — Forbion raises $240M investment fund – FierceBiotechJune 28, 2010 — Shrink Nanotechnologies Enters into Technology Integration and Development … – [...]

GM food back on the menu in Europe?CatererSearchSpelman, a former director of a biotech lobbying firm, believes the technology could be beneficial if the crops reduced the use of chemicals or gave …
and more »

Related PostsJuly 17, 2010 — Scientist leading GM crop test defends links to US biotech giant Monsanto – The GuardianJuly 13, 2010 [...]

Biotech racks up second cancer toolOtago Daily TimesThere was a high incidence of colorectal cancer in Japan, Australia, New Zealand, Europe and North America. The findings will be presented to the scientific …

Related PostsSeptember 8, 2010 — Transgene teams with Jennerex in $116M cancer pact – FierceBiotechSeptember 3, 2010 — Forbion raises $240M investment fund [...]